REBEKAH EDWARDS: Open Payments
NPI 1225444052 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$9,289 in 38 payments from 14 companies in 2025. Trend: 2023 $6,578 · 2024 $26,691 · 2025 $9,289
Consulting: $3,740Speaker / faculty: $3,410Travel & lodging: $1,359Food & beverage: $762Education: $17
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 21 | $8,918 |
| Insmed, Inc. | 3 | $58 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $51 |
| Pharmacosmos Therapeutics Inc. | 1 | $33 |
| Vifor Pharma, Inc. | 1 | $32 |
| Amgen Inc. | 2 | $30 |
| Actelion Pharmaceuticals US, Inc. | 1 | $29 |
| Grifols USA, LLC | 1 | $25 |
| ANI Pharmaceuticals, Inc. | 1 | $25 |
| Verona Pharma, Inc. | 1 | $21 |
Products named: JASCAYD, Arikayce, MONOFERRIC, Zemaira, TEZSPIRE, LIVTENCITY, OPSUMIT, OFEV.
Industry payments across AZ — which companies pay providers there.
